Teladoc (TDOC) PT Raised to $110 at RBC Capital

RBC Capital analyst Sean Dodge raised the price target on Teladoc (NYSE: TDOC) to $110.00 (from $100.00) while maintaining an Outperform rating.

The analyst commented, "The InTouch acquisition strengthens our confidence in TDOC's ability to sustain 20-30% organic revenue growth longer, better balances its strategy (provider vs. payer/consumer) and further distances it from peers as the virtual health leader. The 4Q pre-announcement also points to a brighter International outlook. That said, we are moderating our EBITDA estimates to reflect a higher expected level of reinvestment."

You May Also Be Interested In

• Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
• B.Riley Downgrades Lantheus Holdings (LNTH) to Neutral